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Thelazia callipaeda ocular infection 
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Worms were retrieved from the left eyes of two dogs presented for unilateral ocular discharge in 
Belgium. Morphological and molecular identification were performed and the parasites were identified 
as Thelazia callipaeda. The history suggested that the infection had been acquired in south-western 
France and southern Italy where the disease has been observed regularly for the last 6 and 12 years, 
respectively. In these two regions, the disease is considered endemic and spreading. To the authors’ 
knowledge, this is the first case report of canine thelaziosis in Belgium.
INTRODUCTION
Thelaziosis is caused by a parasitic nematode belonging to the 
genus Thelazia (Spirurida, Thelaziidae). The viviparous adult 
worm and larvae are found in the conjunctival fornices and naso-
lacrimal duct, and feed on lacrimal secretions. First-stage larvae 
Thelazia callipaeda are ingested by the fruit fly Phortica variegata 
(Diptera: Drosophilidae), which is the intermediate host found in 
Europe (Otranto and others 2006b). Larval development occurs 
in the ovarian follicles of the fly during summer. Late-stage larvae 
migrate to the mouthparts of the fly and are transferred to the 
final host when the fly feeds (Taylor and others 2007).
Thelazia callipaeda has been described in cattle, horses, cats, 
dogs, red foxes, wolves, European rabbits and humans (Hong 
and others 1995, Otranto and Traversa 2004, Otranto and others 
2007, Otranto and Dutto 2008). In dogs, Thelazia californien-
sis in North America and T. callipaeda in Asia have been identi-
fied (Taylor and others 2007). The latter was first described in 
Europe, in Piedmont (Italy) 23 years ago (Rossi and Bertaglia 
1989). This “oriental eyeworm” has now been detected in France 
(Ruytoor and others 2010), Switzerland (Malacrida and others 
2008), Germany (Magnis and others 2010), Spain (Miro and 
others 2011), The Netherlands and Belgium (Otranto and others 
2005, Janssens and Claerebout 2006). 
HISTORY
A seven-year-old, spayed female golden retriever was presented to 
the University of Liège with a 5-month history of intermittent dis-
charge from the left eye (OS). Two days before  presentation, the 
owner noticed a redness with a purulent discharge OS. This dog 
had been living in the Lot department in the southwest of France 
for several years before moving to Belgium. The second patient, 
an 11-year-old entire male Labrador retriever, was presented with 
a 3-month history of discharge OS. In the past 3 years, this dog 
had travelled annually to southern Italy (Basilicata), and once to 
the northeast of France (Alsace).
Clinical examination
The clinical examination of both dogs was unremarkable. The 
female was on treatment for hypothyroidism with 300 µg of 
l-thyroxine twice daily (Forthyron 200; Eurovet Animal Health). 
A Schirmer tear test (Schirmer Tear Test; Schering-Plough 
Animal Health Corp.) was 22 and 20 mm/minute in the left 
and right eyes of the male dog and 25 and 21 mm/minute in 
the female dog, respectively. In the female, purulent conjuncti-
vitis was diagnosed OS, with severely hyperaemic palpebral and 
bulbar conjunctivae covered with large lymphoid follicles. In the 
male, mild follicular hyperplasia was present on the bulbar aspect 
of the nictitating membrane OS. In both patients, four thread-
like motile white parasites were observed in the conjunctival for-
nices OS (Fig 1). Fluorescein testing (Fluorescein; Haag-Streit 
International) was negative in both dogs. Bilateral nuclear scle-
rosis was present in both dogs. The male dog had a translucent 
iris cyst in the left anterior chamber. Bilateral small foci of retinal 
dysplasia in the tapetal area were present in the female with small 
posterior polar subcapsular lenticular opacities OS. The rest of 
the ocular examination was within normal limits in both dogs.
Treatment and outcome
The parasites were removed using fine serrated forceps and 
cotton tip applicators in both dogs. Topical anaesthesia with 4 
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360 µm wide at the widest point) were identified microscopically. 
All specimens were identified as T. callipaeda according to their 
size, the presence of a buccal capsule, the transversally striated 
cuticle, the position of the vulva located anterior to the oesoph-
agus-intestinal junction and the presence of numerous rounded 
first-stage larvae in the distal uterus in the female worms and the 
presence of two dissimilar spicules in the caudal bursa of the male 
worm (Otranto and others 2003b) (Fig 2).
Molecular identification was performed with the worms col-
lected as previously reported (Otranto and others 2005). Briefly, 
genomic DNA was isolated from the worms using QIAmp DNA 
Mini Kit (Qiagen GmbH). The cytochrome c oxidase subunit 1 
(cox1) (689 bp) was amplified using described primers and a com-
mercial kit (Taq PCR Master Mix; Qiagen GmbH). The ampli-
fication products were purified using a commercial kit (MSB® 
Spin PCRapace; Invitek) and sequenced with a genetic analyser 
(ABI PRISM® 3100; Applied Biosystem) and compared with the 
BLASTn genomic database (McGinnis and Madden 2004). The 
cox1 sequences obtained were identical to the sequence represent-
ing haplotype 1 (h1) (GenBank accession number AM042549) 
(Otranto and others 2005).
DISCUSSION
Both dogs affected by ocular thelaziosis were living in Belgium 
when diagnosed, but had travelled and stayed in various regions 
of southern Europe. In a previous study, T. callipaeda was iden-
tified from a dog living in the Netherlands, which had spent 3 
months in the Dordogne department (Otranto and others 2005). 
There is another report describing a case of canine Thelaziosis 
in Belgium but the information included is limited, although it 
was noted that the dog had travelled to the Lombardia region 
(Italy) (Janssens and Claerebout 2006). In western Europe, 
canine thelaziosis is now considered endemic and widespread in 
south-western France (Dordogne department, close to the Lot) 
(Dorchies and others 2007), in southern Switzerland and all of 
mg/mL oxybuprocaine hydrochloride (0·5% Unicaïne; Thea 
Pharma) was instilled before parasite removal. The specimens 
were collected in 70% ethanol for parasitologic identification. 
Both patients were treated systemically with one dose of spot-on 
dermal application of 10% imidacloprid and 2·5% moxidectin 
(Advocate Spot-On; Bayer HealthCare) and topically with a 1 
mg dexamethasone sodium phosphate and 4 mg/mL chloram-
phenicol (Deicol; Meda Pharma) solution thrice daily OS for 4 
weeks.
Four weeks later, the infection had resolved in both dogs. No 
parasites were observed. However, in the female dog, mild follic-
ular conjunctivitis persisted; therefore, the drops were continued 
for 2 further weeks. One month later, both owners reported by 
telephone that the eyes appeared normal.
Morphologic and molecular identification
Five female worms (15·5 ±2·5 mm long and 435 ±50 µm wide 
at the widest point) and one male worm (10·2 mm long and 
FIG 1. Thela zia callipaeda on the inflamed conjunctival bulbar surface of 
the nictitating membrane
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amongst humans and pets in rural areas (Ruytoor and others 
2010). However, human thelaziosis is considered a neglected 
disease. This could be due to its high prevalence in socio-eco-
nomically disadvantaged communities and the lack of aware-
ness amongst physicians across Europe concerning the zoonotic 
potential of this parasite (Shen and others 2006). 
To the authors’ knowledge, this is the first case report of 
canine Thelaziosis in Belgium confirmed by microscopic and 
molecular identification. With the presence of definitive hosts 
and an increasing number of dogs travelling to and coming from 
southern endemic regions, the establishment of T. callipaeda in 
larger areas of Europe is possible. Further studies are required 
to explore the vectorial capacity of Phortica spp. in northern 
Europe, especially as the threat of global warming and climatic 
change increases.
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Italy, with a prevalence as high as 60% in the Basilicata region 
(Otranto and others 2003a).
The potential introduction and establishment of T. callipae-
da in Belgium would depend on the presence of the fly vector. 
According to a previous study (Otranto and others 2006a) based 
on a predictive geoclimatic model, the vector, P. variegata, would 
be able to survive and multiply in Belgium. However, the pres-
ence of P. variegata has not yet been recorded in Belgium (Royal 
Belgian Institute of Natural History, http://www.species.be).
The disease can be subclinical or symptomatic, with 15·4 to 
81·4% of infected dogs showing clinical signs (Malacrida and 
others 2008, Miro and others 2011). Affected dogs typically pres-
ent with follicular conjunctivitis, a mucoid to purulent discharge 
and lymphoid tissue hyperplasia, as observed in the present cases 
(Ruytoor and others 2010). Conjunctival petechiae and oedema, 
epiphora (Miro and others 2011), keratitis and corneal ulcers are 
less frequently described (Dorchies and others 2007). Clinical 
signs may result from the mechanical damage to the ocular sur-
faces by the cuticle and parasite movement (Otranto 2011). The 
foreign body sensation can lead to self-mutilation and secondary 
infection of the eyelids, conjunctiva and cornea. Epiphora can 
result from nasolacrimal duct obstruction by the parasites (Jans-
sens and Claerebout 2006). In dogs, the severity of symptoms 
did not appear to correlate with the number of worms found 
(Miro and others 2011). Because of the similarity in clinical 
signs, thelaziosis should be included in the differential diagnosis 
of infectious or allergic conjunctivitis, dacryocystitis and keratitis 
(Otranto 2011).
A diagnosis is made by finding the adult worms on the ocu-
lar surfaces, as observed in the present cases and/or in the naso-
lacrimal ducts. Diagnosis can be difficult when most parasites 
are in a larval stage, when few adult nematodes are present or 
when parasites are located within the excretory ducts of the lac-
rimal glands. The latter location has not been described in dogs 
to the author’s knowledge. Identification of the worms can be 
performed by microscopic and molecular examination. Mito-
chondrial genes such as the cox1 have proven useful for such 
investigations because of the relatively rapid evolutionary rates of 
these genes and the availability of gene sequences for filaroids in 
databanks (Hu and others 2004). In this study, the use of both 
techniques led to the identification of the same species: T. cal-
lipaeda (cox1 h1).
Treatment of the condition is by removal of the worms. Topi-
cal corticosteroids and antibiotics can be used to treat the associ-
ated conjunctivitis and prevent bacterial contamination. A single 
dose of 10% imidacloprid and 2·5% moxidectin by spot-on der-
mal application (Advocate Spot-On®; Bayer) has previously been 
shown to be effective (Bianciardi and Otranto 2005, Janssens and 
Claerebout 2006). These treatment regimes were performed in 
the present cases. One percent moxidectin eye drops in an aque-
ous solution, administered as a single dose, was also highly effi-
cient and well tolerated in infected dogs (Lia and others 2004).
In the southwest of France and the northwest of Italy, four 
cases of human T. callipaeda infection were diagnosed (Ruytoor 
and others 2010). Wild fauna, particularly red foxes and hares, 
probably plays a role in maintaining and spreading the  nematode 
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1. Replace (Ins) Tool – for replacing text. 
 
Strikes a line through text and opens up a text 
box where replacement text can be entered. 
How to use it 
x Highlight a word or sentence. 
x Click on the Replace (Ins) icon in the Annotations 
section. 
x Type the replacement text into the blue box that 
appears. 
This will open up a panel down the right side of the document. The majority of 
tools you will use for annotating your proof will be in the Annotations section, 
pictured opposite. We’ve picked out some of these tools below: 
2. Strikethrough (Del) Tool – for deleting text. 
 
Strikes a red line through text that is to be 
deleted. 
How to use it 
x Highlight a word or sentence. 




3. Add note to text Tool – for highlighting a section 
to be changed to bold or italic. 
 
Highlights text in yellow and opens up a text 
box where comments can be entered. 
How to use it 
x Highlight the relevant section of text. 
x Click on the Add note to text icon in the 
Annotations section. 
x Type instruction on what should be changed 
regarding the text into the yellow box that 
appears.
4. Add sticky note Tool – for making notes at 
specific points in the text. 
 
Marks a point in the proof where a comment 
needs to be highlighted. 
How to use it 
x Click on the Add sticky note icon in the 
Annotations section. 
x Click at the point in the proof where the comment 
should be inserted. 
x Type the comment into the yellow box that 
appears. 
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For further information on how to annotate proofs, click on the Help menu to reveal a list of further options: 
5. Attach File Tool – for inserting large amounts of 
text or replacement figures. 
 
Inserts an icon linking to the attached file in the 
appropriate pace in the text. 
How to use it 
x Click on the Attach File icon in the Annotations 
section. 
x Click on the proof to where you’d like the attached 
file to be linked. 
x Select the file to be attached from your computer 
or network. 
x Select the colour and type of icon that will appear 
in the proof. Click OK. 
6. Add stamp Tool – for approving a proof if no 
corrections are required. 
 
Inserts a selected stamp onto an appropriate 
place in the proof. 
How to use it 
x Click on the Add stamp icon in the Annotations 
section. 
x Select the stamp you want to use. (The Approved 
stamp is usually available directly in the menu that 
appears). 
x Click on the proof where you’d like the stamp to 
appear. (Where a proof is to be approved as it is, 
this would normally be on the first page). 
7. Drawing Markups Tools – for drawing shapes, lines and freeform 
annotations on proofs and commenting on these marks. 
Allows shapes, lines and freeform annotations to be drawn on proofs and for 
comment to be made on these marks.. 
How to use it 
x Click on one of the shapes in the Drawing 
Markups section. 
x Click on the proof at the relevant point and 
draw the selected shape with the cursor. 
x To add a comment to the drawn shape, 
move the cursor over the shape until an 
arrowhead appears. 
x Double click on the shape and type any 
text in the red box that appears. 
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